Cytori Therapeutics Inc. (NASDAQ: CYTX) will webcast its second quarter
financial results and management discussion on Monday, August 10, 2009
at 10:30 AM Eastern Time.
The webcast will be available both live and by replay two hours after
the call on the Company’s website (www.cytoritx.com)
under “Events & Webcasts” on the Investor Relations page. A telephone
replay will be available through August 17, 2009 and can be accessed by
dialing +1 800-406-7325 (Passcode: 4126637).
About Cytori
Cytori develops and globally commercializes regenerative medicine
technologies, which provide real-time, point-of-care access to clinical
grade regenerative cells. Our technology is incorporated into two
product families. The Celution®-related products are sold throughout
Europe and Asia primarily into the cosmetic and reconstructive surgery
market and are under evaluation by the U.S. FDA. Our StemSource®
products are sold globally for cell banking and research applications.
We are also developing additional clinical uses of our technology for
the treatment of multiple medical conditions, including cardiovascular
disease, urinary tract disorders, and wound related conditions. To
commercialize our technology, Cytori has partnered with global and
regional leaders in healthcare such as Olympus Corporation, GE
Healthcare, and Green Hospital Supply. www.cytoritx.com
Investor & Media Contact:
Cytori Therapeutics Inc.
Tom
Baker
858-875-5258
tbaker@cytoritx.com
